Antibody maintenance 3 months after complete messenger RNA COVID-19 vaccination in haemodialysis patients

Nephrol Dial Transplant. 2021 Dec 2;36(12):2340-2341. doi: 10.1093/ndt/gfab272.

Authors

José Jesús Broseta¹, Diana Rodríguez-Espinosa¹, José Luis Bedini², Néstor Rodríguez³, Francisco Maduell¹

Affiliations

¹ Department of Nephrology and Renal Transplantation, Hospital Clínic of Barcelona, Barcelona, Spain.
² Department of Biochemistry and Molecular Genetics, Hospital Clínic of Barcelona, Barcelona, Spain.
³ Diaverum Renal Services Haemodialysis Group, Barcelona, Spain.

No abstract available

MeSH terms

Antibodies
COVID-19 Vaccines*
COVID-19*
Humans
RNA, Messenger
Renal Dialysis
SARS-CoV-2
Vaccination

Substances

Antibodies
COVID-19 Vaccines
RNA, Messenger